VEGF-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors

Details for Australian Patent Application No. 2007333735 (hide)

International Classifications

Event Publications

23 July 2009 PCT application entered the National Phase

PCT publication WO2008/077077 Priority application(s): WO2008/077077

5 November 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 29 Sep 2009 2007334054 CP Kelco U.S., Inc. The nature of the amendment is: Amend the name of the co-inventor from Dimasi, Donald and Grasela, Andrew J. to Dimasi, Don and Grazela, Andrew J.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.